A novel homozygous frameshift variant in SPTBN4 causes axonal neuropathy with intellectual disability in a consanguineous family
Rabab Ibrahim,
Ghazala Zafar,
Shafaq Ramzan,
Hijab Zahra,
Asmat Ali,
Shahnaz Ibrahim,
Mathias Toft,
Zafar Iqbal,
Ambrin Fatima
Affiliations
Rabab Ibrahim
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
Ghazala Zafar
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
Shafaq Ramzan
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
Hijab Zahra
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
Asmat Ali
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
Shahnaz Ibrahim
Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan
Mathias Toft
Department of Neurology, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo N-0424, Norway; Institute of Clinical Medicine, University of Oslo, P.O Box 1171, Oslo N-0318, Norway
Zafar Iqbal
Department of Neurology, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo N-0424, Norway; Corresponding authors.
Ambrin Fatima
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan; Corresponding authors.
Introduction: Neurodevelopmental disorder with hypotonia, neuropathy, and deafness (NEDHND, OMIM #617519) is an autosomal recessive condition arising from variations in the SPTBN4 gene. This gene codes for βIV-spectrin, a non-erythrocytic member of the β-spectrin family. Homozygous variants in SPTBN4 disrupt the cytoskeletal machinery responsible for localization of ion channels and functioning of axonal domains, leading to neurological dysfunction. Case presentation: Here, we report three siblings with a homozygous frameshift indel c.1799–1800delGC in the SPTBN4, all presenting with severe muscular hypotonia, dysphagia, absent or limited speech, delayed gross motor development, global developmental delay, and intellectual disability. This condition has been associated with numerous secondary features. Conclusion: The phenotype reported in our family contributes to establishing the core symptoms associated with mutations in SPTBN4, with varying levels of developmental delay, intellectual disability, limited speech, and congenital hypotonia.